Skip Navigation LinksHome > 7 Measure Health Status > Challenges > 14 Diagnostic Tools > A Point-of-Care Diagnostic System for the Developing World
PRIMARY INVESTIGATOR:
Dr. Paul Yager, University of Washington, Washington, United States - US
A Point of Care Diagnostic System for the Developing World
Research ObjectivesProject Progress & Milestones
Collaborators
Project

In the developing world, lack of convenient and accurate tools that can detect and diagnose diseases and other health problems means that many health risks remain undetected or receive inappropriate treatment.

Dr. Yager's team, in collaboration with research groups from private industry as well as the nonprofit sector,  is working to develop a low-cost, easy-to-use device that will rapidly test blood for a range of health problems prevalent in developing countries, such as bacterial infections, nutritional status, and HIV-related illnesses.

The project team is working to produce a platform diagnostic system – the DxBox – that will consist of two components:  

  •  A disposable test or "lab" card, about the size of a credit card that contains all the microfluidic circuitry need to perform as many as 20 different tests using a small sample of blood.
  • A portable reader, about the size of a hand-held computer, designed for easy use in remote locations as well as in hospitals and clinics.

Initially, the project team is focusing on developing a lab card and reader that, using a drop or two of blood as a sample, will allow differential diagnosis of 6 causes of rapid-onset fevers (such as malaria and dengue) that infect tens of millions of people in developing countries each year. During 2008 the project team plans to produce prototype DxBoxes and lab cards that perform both immunoassays and nucleic acid assays for a panel of the fever-causing diseases. In years four and five, the team will optimize performance of the system and investigate additional innovative technologies that may further enhance performance of the DxBox platform.

Project Progress & Milestones:
Verified immunoassay reagents in ELISA format for the pathogens that cause five targeted diseases: malaria, measles, dengue, typhoid, and Rickettsia infections. Demonstrated comparable performance to commercial kits.
The two malaria antigen targets and Rickettsia and measles IgM assays have been verified in two prototype
microfluidic card formats.
Demonstration of rapid, parallel, multiplexed nucleic acid amplification and detection in a microfluidic format that allows multiple measurements while running on a small rechargeable battery.
Nucleic acid assays for the 6 targeted pathogens have been designed and verified in the lab card.
Completion of surveys of potential users in India and Brazil to understand their needs.
BACK TO THE TOP
Collaborators:
Dr Charles F Battrell, Micronics, Washington, United States - US
Dr. Gonzalo Domingo, PATH, Washington, United States - US
Dr. Walt Mahoney, Nanogen, California, United States - US
Dr. Partick Stayton, University of Washington, Washington, United States - US
BACK TO THE TOP

 Project at a Glance

GOAL:
CHALLENGE:
TECHNOLOGY CATEGORY:
DISEASE MODEL:

 Research Map